Biotech Startups

Aer Therapeutics, Inc. is a biopharmaceutical company that specializes in the development of innovative therapies targeting mucus-related issues in lung diseases. The company's primary focus is on creating inhalable treatments to address airway mucus plugs, which are common in conditions like COPD and asthma.

Agile GxP Technologies, Inc. is an innovative company focused on developing specialized software tools tailored for the biopharmaceutical manufacturing industry. Their primary aim is to enhance the efficiency and compliance of biopharmaceutical production processes through advanced technological solutions.

Founded 2022

A clinical-stage biotechnology startup founded in January 2026, focused on developing and commercializing novel therapeutics for respiratory diseases like chronic obstructive pulmonary disease (COPD). The company's business model involves in-licensing late-stage clinical assets and advancing them through global development outside of Greater China. Its lead program is a dual PDE3/4 inhibitor for COPD maintenance treatment.

Founded 2024

Akadeum Life Sciences, Inc. is a biotechnology company that specializes in innovative cell separation technologies tailored for the life sciences industry. Its mission is to enhance the efficiency and scalability of vital sample preparation processes essential for research, diagnostics, and cell therapy applications.

Allay Therapeutics is a pioneering company dedicated to transforming post-surgical pain management. By developing innovative solutions that extend localized pain relief for weeks, they aim to reduce opioid use, minimize addiction risks, and lower healthcare costs associated with traditional pain management.

Allyx Therapeutics is a clinical-stage biotechnology company developing disease-modifying oral therapies for neurodegenerative disorders. Its primary focus is on preserving and protecting synapses to slow or reverse the cognitive decline seen in conditions like Alzheimer's and Parkinson's disease. The company's strategy revolves around its lead compound, which targets the underlying cellular pathology of these diseases rather than just managing symptoms.

Altis Biosystems, Inc. is a pioneering biotechnology firm based in North Carolina, dedicated to enhancing preclinical research through the development of innovative human cell-based models that accurately replicate the gastrointestinal (GI) tract. By providing superior alternatives to traditional cell line and animal models, Altis facilitates improved drug discovery and development, ensuring better predictive insights and reducing reliance on animal testing.

Alzheon, Inc. is a biotechnology company dedicated to developing innovative treatments for Alzheimer's disease. The company focuses on creating therapeutics that aim to slow or halt the progression of Alzheimer's and potentially prevent the onset of clinical symptoms.

Aminex Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies. Their primary strategy is to overcome immune system suppression within the tumor microenvironment by targeting and depleting polyamines, thereby enabling the body's own immune system to attack cancer cells.

Arpeggio Biosciences, Inc. is a biotech innovator specializing in advanced drug discovery solutions through the integration of transcriptomics and artificial intelligence. By leveraging cutting-edge technology and vast datasets, the company is poised to revolutionize the identification of effective treatments for complex diseases.

Aspira Women's Health Inc. is a leading bio-analytical women's health company dedicated to the development of innovative diagnostic tools specifically for gynecologic diseases. With a strong focus on enhancing early detection and risk assessment, particularly for ovarian cancer, Aspira aims to address significant challenges in women's health diagnostics.

Atomwise Inc. is a pioneering technology-enabled pharmaceutical company that employs artificial intelligence to transform the landscape of small molecule drug discovery. By leveraging advanced machine learning techniques, Atomwise aims to streamline the drug development process, making it not only more efficient but also more effective in identifying viable therapeutic candidates.

Aufbau Holdings Ltd. is a biotechnology company focused on creating innovative diagnostic and therapeutic platforms for cancer, ophthalmic diseases, and other medical conditions. Founded in Dublin, Ireland, in March 2019, the company aims to improve patient outcomes by addressing gaps in diagnostic accuracy and treatment efficacy.

Autonomy Bio Inc. is an innovative biotechnology firm focused on advancing RNA-based therapeutics specifically designed to address challenging diseases, with a strong emphasis on oncology and infectious diseases. Leveraging proprietary technology, the company is committed to enhancing the precision and effectiveness of treatments to improve patient outcomes for complex conditions.

Founded 2024

Barnwell Bio, Inc. is an innovative company dedicated to transforming animal health management through advanced environmental monitoring solutions. By addressing the critical issues of disease detection and health management in livestock, the company aims to reduce the substantial economic losses attributable to animal health challenges, which are estimated at $300 billion annually.

Founded 2024

Biocontrol, LLC is a company specializing in biological solutions for pest control, catering to the agricultural and environmental sectors. By focusing on sustainable practices, they help reduce the dependency on chemical pesticides, thereby promoting eco-friendly farming and resource conservation.

BioMark Diagnostics Inc. is dedicated to tackling the critical global issue of early cancer detection, particularly focusing on cancers that are notoriously difficult to diagnose, such as lung, breast, and pancreatic cancers. Their diagnostic solutions aim to significantly improve patient outcomes through earlier and more accurate detection, which is essential for effective treatment and increased survival rates.

BioPhoundry, Inc. is a pioneering biotechnology company that specializes in the development of advanced bioengineering solutions to address complex biological challenges. They are committed to driving innovation in the biotechnology sector through robust research and cutting-edge technology.

Founded 2024

Blue Water Biotechnology Engineering (Macau) Co., Ltd is a biotechnology firm dedicated to developing innovative solutions aimed at addressing the pressing issues of water treatment and environmental protection. The company focuses on creating advanced technologies to tackle water pollution and scarcity, offering a range of products and services designed for efficient water and wastewater management.

Founded 2024

BobcatBio, Inc. is an innovative biotechnology company dedicated to developing advanced cancer therapies that specifically target malignant cells while protecting healthy tissue. Focused on harnessing cutting-edge immunotherapeutic techniques, the company is committed to revolutionizing cancer treatment by creating more effective and less toxic options for patients.

Founded 2020

Carna Biosciences, Inc. is a biotechnology company dedicated to drug discovery and the development of small molecule drugs. The company aims to address unmet medical needs by offering innovative therapeutic solutions in areas where current treatments are either inadequate or non-existent.

Founded 2021

Celestial Therapeutics Inc. is a biopharmaceutical company dedicated to developing innovative therapies aimed at treating, preventing, and curing infectious diseases, inflammatory conditions, and various forms of cancer. With a strong focus on addressing key unmet medical needs, the company integrates cutting-edge technology into its therapeutic solutions.

Cellular Logistics, Inc. is a biotechnology company operating out of Madison, Wisconsin, focused on pioneering advanced regenerative therapies for patients with various cardiovascular diseases. They aim to repair damaged heart tissue and prevent heart failure, particularly in post-heart attack patients, addressing a critical need in cardiac care.

Cerillo, Inc. is a forward-thinking biotechnology company dedicated to advancing microbial research through the development and manufacturing of sophisticated laboratory equipment. By focusing on the intricate challenges of variability and reproducibility in microbiome studies, Cerillo aims to empower researchers with precise tools that enhance scientific discovery.

Chimeron Bio Corp is a forward-thinking biotechnology company headquartered in Philadelphia, focused on the innovation of RNA-based therapeutics and vaccines. Through its proprietary ChaESAR™ platform, the company seeks to enhance the effectiveness of RNA medicines by leveraging self-amplifying RNA technology to create treatments that are more potent and long-lasting than traditional mRNA solutions.

ChromaCode, Inc. is a biotechnology firm focused on revolutionizing diagnostic testing through its advanced PCR multiplexing technology solutions, enhancing efficiency and scalability in biomarker detection. By integrating cloud computing with traditional PCR methods, ChromaCode provides healthcare and research institutions with innovative approaches to diagnostic problem-solving.

Cimeio Therapeutics is a pioneering biotechnology company established in 2020, committed to revolutionizing the treatment landscape for hematologic diseases through innovative cell therapies. The company focuses on addressing the limitations posed by traditional hematopoietic stem cell (HSC) transplantation, particularly the challenges of harsh conditioning regimens and restricted eligibility for patients.

Founded 2024

Claris Biotherapeutics, Inc. is a pioneering biotechnology company dedicated to the development of innovative therapies specifically aimed at treating corneal diseases. With a particular focus on neurotrophic keratitis (NK), a rare and debilitating condition that can lead to significant vision loss, Claris is committed to addressing critical unmet medical needs in this niche area of ocular health.

Consano Bio is an early-stage biotechnology startup founded in 2022 and headquartered in Des Moines, Iowa. The company focuses on developing first-in-category biologic therapeutics to treat painful and debilitating orthopedic conditions. Its core strategy is to target the underlying drivers of disease rather than merely addressing symptoms.

Founded 2022

CoRegen, Inc. is a pioneering biopharmaceutical company dedicated to the development of innovative treatments aimed at aggressive cancers and chronic diseases. Utilizing its proprietary master gene regulator platform, CoRegen works on harnessing the body’s immune system to combat cancer effectively.

Founded 2022

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment through pioneering biologically-based therapies. The company is firmly committed to addressing the pressing challenge of drug resistance in cancer treatment by developing innovative medications that work by reactivating cell death mechanisms.

Cynaptec Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurological and psychiatric disorders. Their primary emphasis lies in addressing significant unmet medical needs, particularly for conditions that currently lack effective treatments.

Founded 2025

DeepkinetiX Inc. is a pioneering company dedicated to revolutionizing the drug development landscape through the innovative application of artificial intelligence and computational modeling techniques. By employing advanced technologies, they strive to optimize pharmacokinetic and pharmacodynamic processes, fostering speed and precision in drug analysis.

Founded 2024

Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of innovative treatments for a range of skin diseases and aesthetic conditions. By leveraging both mechanical and chemical mechanisms, Dermata aims to deliver more effective solutions for dermatologic issues, including acne, psoriasis, and rosacea.

Founded 2021

DMC Biotechnologies, Inc. is a U.S.-based biomanufacturer dedicated to innovating the chemical industry by utilizing sustainable, bio-based production methods for specialty chemicals. By leveraging advanced techniques such as precision fermentation and synthetic biology, the company aims to manufacture high-quality chemical ingredients while minimizing environmental impact.

Elastrin Therapeutics, Inc. is an innovative biotechnology company dedicated to creating groundbreaking therapies aimed at reversing cardiovascular diseases and reinstating elasticity in damaged tissues and organs. By addressing the genetic and environmental factors leading to the deterioration of elastin, the company seeks to enhance the quality of life for patients suffering from related health issues.

Elixirgen Therapeutics, Inc. is a cutting-edge biotechnology firm dedicated to the development of innovative RNA therapeutics aimed at addressing a broad spectrum of medical challenges. The company is committed to providing treatment solutions for rare diseases, cancer, and aging-related conditions that currently have limited therapeutic options.

EnZeta Immunotherapies is an early-stage biotechnology company founded in 2023 and headquartered in Coral Gables, Florida. The company focuses on developing and commercializing T-cell-based immunotherapies for the treatment of solid tumors. Its core strategy is built upon an exclusive patent license secured from the National Institutes of Health (NIH).

Founded 2023

Episteme Prognostics, Inc. is a pioneering precision medicine company dedicated to revolutionizing pancreatic cancer diagnosis and treatment. By focusing on the development of groundbreaking diagnostic tests, the company aims to enhance therapeutic decisions, ultimately improving patient outcomes. Their innovative technology leverages epigenetic biomarkers to provide critical insights into treatment responses for patients diagnosed with this challenging disease.

Founded 2021

Ernexa Therapeutics Inc. is a biotechnology company focused on developing cell therapy solutions for advanced cancer and autoimmune diseases. They use induced pluripotent stem cells (iPSCs) to create induced mesenchymal stem cells (iMSCs) with unique targeting capabilities, enabling the creation of scalable, off-the-shelf therapies. This method eliminates the need for patient-specific solutions.

Evofem Biosciences, Inc. is a biopharmaceutical company focused on women's sexual and reproductive health. They develop and commercialize hormone-free, patient-controlled solutions, providing women with greater control over their health choices. The company addresses unmet needs in contraception, vaginal infections, and sexually transmitted infections.

Formulary Financial, Inc., operating as Formulary Insights, is dedicated to tackling the complexities of market access and optimization in the biopharmaceutical sector. With a strong emphasis on utilizing advanced research methods and data-driven strategies, the company aids pharmaceutical manufacturers in enhancing patient access to treatments while refining product performance and achieving better business outcomes.

Founded 2025

Gliknik Inc. is a pioneering biopharmaceutical company that specializes in the development of innovative biologics aimed at treating cancer and autoimmune disorders. The company's unique approach to drug development sets it apart in the biotech industry, as it seeks to create more effective and accessible alternatives to existing treatments.

Grace Therapeutics, Inc. is a late-stage biopharmaceutical company dedicated to the development of innovative drug delivery technologies aimed at improving treatments for rare and orphan diseases. With a focus on enhancing the performance of existing therapies, the company seeks to expedite the onset of action, augment efficacy, minimize side effects, and provide more user-friendly delivery options for patients.

GT Biopharma, Inc. is a clinical stage biopharmaceutical company dedicated to the advancement of immunotherapy treatments for cancer and other serious diseases. By focusing on the limitations of existing treatments, GT Biopharma aims to provide innovative solutions that are both targeted and effective.

Illexcor Therapeutics, LLC is a biopharmaceutical company dedicated to innovating treatments for sickle cell disease (SCD). Founded in 2020, the company has a mission to address the urgent unmet medical needs by developing oral therapies that effectively manage SCD on a global level.

Founded 2023

Immunic, Inc. is a late-stage clinical biotechnology company focused on developing novel oral therapies for chronic inflammatory, autoimmune, neurologic, and gastrointestinal diseases. The company's primary focus is on its lead drug candidate, vidofludimus calcium, which is in Phase 3 trials for the treatment of multiple sclerosis. Immunic aims to address unmet needs by targeting mechanisms like Nurr1 activation and DHODH inhibition to offer neuroprotective and anti-inflammatory benefits.

Infinity Bio, Inc. is an innovative biotechnology company focused on providing advanced antibody profiling services. Established in 2023 and headquartered in Baltimore, Maryland, the company utilizes cutting-edge technology developed at Johns Hopkins University to address the complexities of antibody responses within the immune system.

Founded 2023

Integrity Laboratories, Inc. is a pioneering biotechnology company committed to revolutionizing the management of infectious diseases through high-complexity clinical diagnostics. By offering cutting-edge molecular diagnostic testing solutions, the company strives to enhance the speed and accuracy of infectious disease detection and treatment across the healthcare landscape.

Founded 2022

iOncologi, Inc. (iOi) is an innovative biotechnology company dedicated to pioneering novel immunotherapies for the treatment of refractory cancers and infectious diseases. With a strong emphasis on addressing the unmet medical needs of cancer patients who do not respond to existing treatments, iOncologi is at the forefront of transforming cancer therapy through advanced scientific research and development.

IVIEW Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing innovative treatments for ocular diseases. By focusing on unmet medical needs in the ophthalmology sector, the company aims to create effective therapies for conditions including dry eye disease, conjunctivitis, myopia, glaucoma, and presbyopia.

Lapix Therapeutics Inc. is a clinical-stage biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative oral therapeutics that restore immune system function for patients with autoimmune diseases. Through a patient-centric approach, Lapix Therapeutics is pioneering treatments that enhance the body's natural immune tolerance.

Latigo Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of non-opioid pain medicines. Based in Thousand Oaks, CA, the company leverages advanced technologies, including artificial intelligence and machine learning, to create innovative treatments that address the unmet needs in pain management.

Liberation Labs Holdings Inc. specializes in the commercialization of precision fermentation technology, focusing on the production of sustainable bioproducts. The company is dedicated to bridging the gap between innovative biotechnology advancements and their commercial-scale production, providing solutions that address the demand for environmentally friendly products.

Founded 2022

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing groundbreaking therapies specifically for chronic rhinosinusitis (CRS), a prevalent inflammatory condition affecting the nasal passages and sinuses. By leveraging innovative technologies, Lyra aims to provide effective solutions for CRS patients who often endure ineffective treatments and potentially invasive surgeries.

Founded 2024

Maxymune Therapeutics, Inc. is a pioneering biopharmaceutical company focused on developing innovative immunotherapies aimed at treating various immune-related diseases. With a commitment to advancing patient care through scientific research and development, Maxymune strives to harness the power of the immune system to improve health outcomes.

Founded 2023

Medici Therapeutics, Inc. is a biotechnology company focused on developing advanced cancer treatments within the immunotherapy sector. The company's primary focus is on advancing tumor-infiltrating lymphocyte (TIL) therapies by leveraging novel insights into cancer immunology, particularly how cancer cells evade immune responses.

Founded 2021

Medicovestor is an early-stage biopharmaceutical company founded in 2023, focused on developing next-generation antibody-drug conjugate (ADC) platforms. The company aims to create precision medicines for solid tumors like pancreatic and ovarian cancer by overcoming the limitations of existing ADCs, particularly in tumors with low antigen expression.

Montara Therapeutics, Inc. is a preclinical-stage biopharmaceutical company dedicated to the development of innovative therapies for neurological diseases and brain cancers. With a strong emphasis on minimizing peripheral side effects and enhancing the efficacy of treatments, Montara is at the forefront of addressing critical challenges in the neurological therapeutics space.

Founded 2022

Myrtelle Inc. is a clinical-stage gene therapy company carrying the mission of developing innovative treatments for neurodegenerative diseases that primarily affect myelin and white matter in the brain. With a particular focus on Canavan disease, the company addresses critical gaps in treatment options for rare genetic disorders of the central nervous system, aiming to improve patient outcomes significantly.

Founded 2021

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company dedicated to developing pioneering treatments for central nervous system diseases, focusing primarily on brain cancers such as glioblastoma. The company's innovative approaches seek to overcome the formidable challenge of delivering therapeutics across the blood-brain barrier, which has historically hindered effective treatment options.

Founded 2023

Neutrolis Inc. is a clinical-stage biotechnology firm that specializes in developing innovative therapies aimed at autoimmune and inflammatory diseases. The company's unique approach focuses on targeting Neutrophil Extracellular Traps (NETs), which are implicated in tissue damage and chronic inflammation associated with several immune-mediated disorders, such as lupus and dry eye disease, as well as severe complications from conditions like COVID-19.

Newleos Therapeutics, Inc. is a pioneering clinical-stage neuroscience company focused on the innovation of therapies for neuropsychiatric disorders. With a commitment to addressing the pressing unmet needs in mental health, Newleos is dedicated to developing effective tools for anxiety and substance use disorders, impacting millions across the United States.

Founded 2024

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for central nervous system disorders, with a particular focus on suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The company seeks to fulfill significant unmet medical needs within these areas by delivering novel treatment options that promise enhanced efficacy and safety.

NurExone Biologic Inc. is a publicly traded biopharmaceutical company based in Canada, specializing in the development of innovative treatments for neurological injuries, particularly focusing on spinal cord injuries. Their research and products aim to address the significant need for effective recovery solutions for patients suffering from acute spinal cord trauma.

Odyssey Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory diseases. The company's strategy involves targeting upstream signaling nodes in the innate immune system to prevent pathological inflammation before it starts, aiming to induce long-lasting remission for patients.

Founded 2021

Oncocyte Corporation is a leading molecular diagnostics company committed to enhancing patient outcomes through advanced diagnostic testing solutions tailored for oncology and transplant care. By focusing on delivering actionable insights, Oncocyte empowers healthcare professionals to make informed medical decisions critical to patient treatment pathways.

Oncotelic Therapeutics, Inc. is a publicly traded, clinical-stage biotechnology company developing RNA therapeutics and small-molecule drugs for immuno-oncology and virology. The company's primary focus is on advancing its lead candidate, OT-101, which targets the TGF-β pathway to treat solid tumors and severe viral diseases. Oncotelic also leverages a proprietary AI platform to support its research and development efforts.

Ostherapies is a clinical-stage biotechnology company focused on developing immunotherapies that activate the patient's immune system to fight HER2-expressing cancers. The firm's primary objective is to advance its lead therapy through clinical trials, initially targeting osteosarcoma, a cancer that has not seen new treatments in over three decades.

Outlook Therapeutics is a pioneering biopharmaceutical company specializing in the development and commercialization of ophthalmic medications. The company is committed to addressing significant unmet medical needs in the treatment of retinal diseases through innovative therapeutic solutions.

PanTher Therapeutics, Inc. is a clinical-stage oncology company that focuses on revolutionizing cancer treatment through localized therapy. By addressing the inefficiencies of systemic drug delivery, PanTher aims to enhance cancer therapies and minimize side effects for patients.

Parcel Biosciences is a seed-stage biotechnology startup founded in 2023, focused on developing next-generation RNA therapeutics. The company is creating a nanoparticle-free delivery system for mRNA medicines, aiming to overcome the technical limitations of current lipid nanoparticle technologies. This innovative approach is designed to enable targeted delivery of therapeutics to specific cell types, expanding the potential applications of mRNA beyond vaccines.

Founded 2024

PhAST Corp. is a biotechnology company specializing in the transformation of infectious disease diagnostics through innovative rapid diagnostic technology. With a focus on minimizing turnaround times for pathogen detection and testing, PhAST Corp. aims to enhance patient care by enabling timely treatment decisions.

Pheast Therapeutics, Inc. is a preclinical-stage biotechnology company focused on developing novel immuno-oncology therapies. The company is pioneering a new approach to cancer treatment by targeting innate immune evasion pathways, specifically harnessing the power of macrophages to recognize and eliminate cancer cells. Pheast's innovative approach aims to address the limitations of current immunotherapies and offer solutions for aggressive cancers.

Founded 2020

Phio Pharmaceuticals Corp. is a biotechnology company specializing in the development of groundbreaking therapeutics, particularly in the field of immuno-oncology. Utilizing their proprietary technology platform, they focus on addressing unmet medical needs to potentially enhance cancer treatment outcomes.

Pluri Inc. is a forward-thinking biotechnology company focused on developing innovative cell-based products and technologies. By addressing critical challenges in the realms of medicine, food production, and environmental sustainability, Pluri Inc. aims to revolutionize the landscape of regenerative medicine and sustainable agriculture.

Pulmotherapeutics Inc. is a biopharmaceutical company dedicated to creating innovative therapies for respiratory diseases. It focuses on developing advanced treatments for severe pulmonary conditions, making use of cutting-edge technology.

Founded 2024

Rakuten Medical, Inc. is a biotechnology company focused on developing advanced cancer treatments through their innovative photoimmunotherapy technology. Their mission is to provide more precise and effective therapeutic options, specifically targeting cancer cells to minimize collateral damage to healthy tissues.

Resolute Science, Inc. is a biotechnology company dedicated to advancing cancer treatment through innovative therapeutic strategies. The company specializes in addressing the challenges of solid tumor cancers, with a focus on overcoming recurrence and drug resistance.

Founded 2020

Restora Medical, Inc. is an innovative biotechnology company founded in 2023 and based in Irvine, California. The company is dedicated to developing cutting-edge medical technologies and solutions within the healthcare industry, aiming to address significant health-related challenges through novel biological and technological advancements.

Founded 2023

Revi Life Sciences, Inc. is a biotechnology-centric company specializing in innovative solutions that enhance the understanding and modeling of human vascular physiology. Their primary focus is on developing in-vitro models that replicate human vascular systems through engineered micro-environments, facilitating advanced research and development within the life sciences sector.

Founded 2023

RNAV8 Bio, Inc. is an innovative biotechnology company dedicated to enhancing the efficacy of mRNA therapeutics. By harnessing advanced technologies like machine learning and artificial intelligence, RNAV8 aims to revolutionize the field of mRNA-based drug development for a wide array of diseases.

Founded 2022

Scorpius Holdings, Inc. is a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing through its subsidiary, Scorpius BioManufacturing. Based in Morrisville, North Carolina, with facilities in San Antonio, Texas, the company provides comprehensive services including process development and analytical testing to pharmaceutical and biotech companies.

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and discovering next-generation cancer therapeutics. The company utilizes its proprietary biologics platform to create treatments that selectively target the tumor microenvironment. Its primary goal is to advance its pipeline candidates through clinical trials and eventually commercialize them to treat various forms of cancer.

seqWell Inc. is a biotechnology company dedicated to advancing the efficiency and accuracy of DNA/RNA library preparation workflows for next-generation sequencing (NGS). By pioneering innovative solutions, seqWell streamlines complex processes, making genetic testing more accessible and reliable for laboratories worldwide.

Surrozen, Inc. is a biotechnology firm headquartered in South San Francisco, California, dedicated to pioneering innovative regenerative medicines through the activation of the Wnt signaling pathway. This critical mechanism serves as a foundation for tissue repair and regeneration, positioning Surrozen at the forefront of advanced therapeutic solutions for diverse medical conditions.

Founded 2021

Syenex, Inc. is at the forefront of biotechnology, specializing in advanced delivery technologies for genetic medicine. The company is dedicated to enhancing the field of cell and gene therapy by providing innovative solutions for both in vivo and ex vivo genetic modifications, thereby amplifying the therapeutic potential and clinical impact of these therapies.

Founded 2022

Syndex Bio is a pioneering biotechnology company dedicated to revolutionizing the pace and depth of biological discovery through the application of advanced technologies. Established in 2022 and located in Cambridge, UK, the company focuses on creating innovative tools designed to enhance research capabilities across various fields in biology and medicine.

Founded 2022

Synlico Inc. is an AI-powered drug discovery company dedicated to transforming traditional approaches in oncology through the development of engineered T cell therapies tailored to combat solid tumors. By harnessing advanced computational techniques, Synlico leads a paradigm shift in understanding and addressing the complexities of cellular behavior in the tumor microenvironment.

Founded 2021

Syntis Bio, Inc. is a pioneering biotechnology company focused on transforming oral therapeutics through innovative solutions targeting the small intestine. By leveraging its proprietary SYNT™ platform, the company enhances the absorption and effectiveness of treatments for prevalent and challenging conditions such as obesity, diabetes, and rare diseases.

Founded 2022

Tectonic Therapeutic, Inc. is a pioneering biotechnology company based in Watertown, Massachusetts, dedicated to the discovery and development of advanced therapeutic proteins and antibodies. The company primarily focuses on harnessing the potential of G-Protein Coupled Receptors (GPCRs), which are integral to numerous biological processes and disease pathways.

Telos Biotech is a biotechnology startup that develops technologies to enhance the manufacturing of cell therapies. The company, launched by Cambrian Bio in 2022, focuses on addressing telomere shortening during cell expansion to improve the function, longevity, and robustness of therapeutic cells used to treat cancer and age-related diseases.

Third Pole, Inc. is an innovative biotechnology company dedicated to developing and delivering essential life-sustaining therapies for cardiopulmonary conditions. The company specializes in creating portable, tankless inhaled nitric oxide (iNO) delivery systems to enhance accessibility and patient care.

Topaz Biosciences, Inc. is a biotechnology company that specializes in developing innovative solutions for skin health, with a strong emphasis on harnessing the potential of the skin microbiome. Established in 2022 and based in Emeryville, California, the company is committed to addressing common skin issues such as eczema and acne through scientifically-backed enzyme technology.

Founded 2022

Trinity Nuclein Series C QP Investors LLC is an investment entity associated with Trinity Investors, a distinguished private equity firm. This vehicle is primarily aimed at funding Nuclein, a biotechnology innovator dedicated to creating advanced rapid diagnostic testing solutions for infectious diseases.

Founded 2025

Vaxess Technologies, Inc. is a pioneering life sciences company focused on the development of innovative vaccine and therapeutic delivery technologies. Their flagship product, the MIMIX™ platform, is a cutting-edge transdermal patch system that aims to make vaccines and therapeutics more effective and accessible, particularly in challenging environments.

Vivace Therapeutics, Inc. is a pioneering biotechnology firm focused on creating innovative cancer treatments that specifically target the Hippo-YAP signaling pathway. The company aims to deliver solutions for cancer patients with limited options, particularly those suffering from challenging malignancies driven by pathway dysregulation.

VoxCell BioInnovation Inc. is a pioneering biotechnology company specializing in innovative solutions to enhance the drug development process, particularly within the oncology sector. By focusing on reducing the high failure rate in drug development, VoxCell aims to streamline preclinical testing and ultimately decrease both time and costs involved.

Founded 2020

Xilis, Inc. is a biotech company focused on transforming cancer treatment through innovative technologies that enable personalized medicine. By leveraging its proprietary MicroOrganoSphere™ technology, Xilis offers tailored therapeutic solutions that match cancer patients with the most effective treatments based on their individual tumor biology.

Zeo ScientifiX, Inc., formerly known as Organicell Regenerative Medicine, Inc., is a publicly traded, clinical-stage biopharmaceutical company. It focuses on researching, developing, and manufacturing biological therapeutics derived from perinatal sources to treat degenerative diseases and support regenerative medicine applications.

Zero Point Five Therapeutics, Inc., also known as ZP5 Therapeutics, is a biotechnology company focused on developing effective treatments for neglected tropical diseases, particularly soil-transmitted helminthiasis (STH). The company aims to create accessible therapies for diseases that disproportionately affect marginalized communities worldwide, addressing a critical health crisis caused by intestinal parasitic infections.

Zhongrong Technology Group Co., Ltd is a prominent player in the bio-chemical and fine chemical industries, specializing in the production of high-quality chemical products. The company meets the growing demand for essential raw materials in pharmaceuticals, agriculture, and various industrial applications through advanced technological innovation.

Founded 2024

Zucara Therapeutics Inc. is a pioneering life sciences company focused on diabetes treatment, specifically dedicated to developing innovative solutions to combat hypoglycemia in individuals with diabetes. Through advanced therapeutics, Zucara aims to improve the quality of life for those affected by insulin-dependent diabetes by providing preventive measures against the potentially dangerous side effects of insulin therapy.